A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

NCT05781386 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Cutaneous T Cell Lymphoma

Interventions

DRUG: SIM1811-03 or in combination with Sintilimab injectiont

Sponsor

Jiangsu Simcere Biologics Co., Ltd